These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24721247)

  • 1. Cellular reprogramming in skin cancer.
    Song IY; Balmain A
    Semin Cancer Biol; 2015 Jun; 32():32-9. PubMed ID: 24721247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapy.
    Vicente-Dueñas C; Hauer J; Ruiz-Roca L; Ingenhag D; Rodríguez-Meira A; Auer F; Borkhardt A; Sánchez-García I
    Semin Cancer Biol; 2015 Jun; 32():3-9. PubMed ID: 24530939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dualistic origin of human tumors.
    Liu J
    Semin Cancer Biol; 2018 Dec; 53():1-16. PubMed ID: 30040989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular Pliancy and the Multistep Process of Tumorigenesis.
    Puisieux A; Pommier RM; Morel AP; Lavial F
    Cancer Cell; 2018 Feb; 33(2):164-172. PubMed ID: 29438693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenopatients 2.0: reprogramming the epigenetic landscapes of patient-derived cancer genomes.
    Menendez JA; Alarcón T; Corominas-Faja B; Cuyàs E; López-Bonet E; Martin AG; Vellon L
    Cell Cycle; 2014; 13(3):358-70. PubMed ID: 24406535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status in cancer cell reprogramming and its clinical implications.
    Izgi K; Canatan H; Iskender B
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):371-383. PubMed ID: 27620745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Making of Leukemia.
    González-Herrero I; Rodríguez-Hernández G; Luengas-Martínez A; Isidro-Hernández M; Jiménez R; García-Cenador MB; García-Criado FJ; Sánchez-García I; Vicente-Dueñas C
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming of mesenchymal stem cells by oncogenes.
    Eid JE; Garcia CB
    Semin Cancer Biol; 2015 Jun; 32():18-31. PubMed ID: 24938913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How tumour cell identity is established?
    Sánchez-García I
    Semin Cancer Biol; 2015 Jun; 32():1-2. PubMed ID: 25931389
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncogene-induced plasticity and cancer stem cells.
    Rapp UR; Ceteci F; Schreck R
    Cell Cycle; 2008 Jan; 7(1):45-51. PubMed ID: 18196970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Cellular Identity in Cancer.
    Roy N; Hebrok M
    Dev Cell; 2015 Dec; 35(6):674-84. PubMed ID: 26702828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatic stem cells and the origin of cancer.
    Martínez-Climent JA; Andreu EJ; Prosper F
    Clin Transl Oncol; 2006 Sep; 8(9):647-63. PubMed ID: 17005467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
    Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
    In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cell technology for dissecting the cancer epigenome.
    Semi K; Yamada Y
    Cancer Sci; 2015 Oct; 106(10):1251-6. PubMed ID: 26224327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic reprogramming in cancer.
    Suvà ML; Riggi N; Bernstein BE
    Science; 2013 Mar; 339(6127):1567-70. PubMed ID: 23539597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological mimicking of caloric restriction elicits epigenetic reprogramming of differentiated cells to stem-like self-renewal states.
    Oliveras-Ferraros C; Vazquez-Martin A; Menendez JA
    Rejuvenation Res; 2010 Oct; 13(5):519-26. PubMed ID: 21047255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell Reprogramming in Tumorigenesis and Its Therapeutic Implications for Breast Cancer.
    Chu PY; Hou MF; Lai JC; Chen LF; Lin CS
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer epigenetics: from disruption of differentiation programs to the emergence of cancer stem cells.
    Scaffidi P; Misteli T
    Cold Spring Harb Symp Quant Biol; 2010; 75():251-8. PubMed ID: 21047903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties.
    Paranjape AN; Mandal T; Mukherjee G; Kumar MV; Sengupta K; Rangarajan A
    Oncogene; 2012 Apr; 31(15):1896-909. PubMed ID: 21874052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dedifferentiation and
    Guo Y; Wu W; Yang X; Fu X
    Mol Med Rep; 2022 Dec; 26(6):. PubMed ID: 36321786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.